AVTX (STOCKS)
Avalo Therapeutics, Inc. Common Stock
$19.450000
-0.100000 (-0.51%)
Prev close: $19.550000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Garry Arthur Neil
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,130.95M
- Employees
- 23
- P/E (TTM)
- -4.13
- P/B (TTM)
- 2.31
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
10
Strong Buy
10
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.83 | $-0.59 | -0.2365 | -39.85% |
|
Mar 2026 (Q1)
|
$-0.98 | $-1.05 | +0.0661 | +6.32% |
|
Dec 2025 (Q4)
|
$-1.13 | $-1.49 | +0.3633 | +24.33% |
|
Sep 2025 (Q3)
|
$-2.19 | $-1.69 | -0.4981 | -29.44% |